27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) shares are trading higher following reports indicating the FDA is expected to fully approve Pfizer and BioNTech's COVID-19 vaccine this week.
The two-dose shot was first cleared in December by the agency on an emergency use basis for people 16 years and older. The emergency designation allows for products to be distributed during public-health crises based on the best available evidence, said in the WSJ report.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Pfizer also announced it will acquire Trillium Therapeutics for $18.50 per share, implying an equity value of $2.26 billion.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19.
BioNTech's stock was trading about 7.4% higher at $374.40 per share Monday morning.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas.
Pfizer's stock was trading about 4% higher at $50.65 per share.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.